Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histone lysine demethylases as targets for anticancer therapy
Jonas W. Højfeldt, Karl Agger, Kristian Helin
Nature Reviews Drug Discovery (2013) Vol. 12, Iss. 12, pp. 917-930
Closed Access | Times Cited: 437

Showing 1-25 of 437 citing articles:

Writing, erasing and reading histone lysine methylations
Kwangbeom Hyun, Jongcheol Jeon, Kihyun Park, et al.
Experimental & Molecular Medicine (2017) Vol. 49, Iss. 4, pp. e324-e324
Open Access | Times Cited: 995
The emerging complexity of gene fusions in cancer
Fredrik Mertens, Bertil Johansson, Thoas Fioretos, et al.
Nature reviews. Cancer (2015) Vol. 15, Iss. 6, pp. 371-381
Closed Access | Times Cited: 629
Epigenetic regulation of ageing: linking environmental inputs to genomic stability
Bérénice A. Benayoun, Elizabeth A. Pollina, Anne Brunet
Nature Reviews Molecular Cell Biology (2015) Vol. 16, Iss. 10, pp. 593-610
Open Access | Times Cited: 562
Harnessing the plasticity of CD4+ T cells to treat immune-mediated disease
Michel DuPage, Jeffrey A. Bluestone
Nature reviews. Immunology (2016) Vol. 16, Iss. 3, pp. 149-163
Closed Access | Times Cited: 448
The landscape and therapeutic relevance of cancer-associated transcript fusions
Kosuke Yoshihara, Qing Wang, Wandaliz Torres‐García, et al.
Oncogene (2014) Vol. 34, Iss. 37, pp. 4845-4854
Open Access | Times Cited: 433
The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development
Ana Ortega-Molina, Isaac W. Boss, Andrés Canela, et al.
Nature Medicine (2015) Vol. 21, Iss. 10, pp. 1199-1208
Open Access | Times Cited: 393
Epigenetics in cancer stem cells
Tan Boon Toh, Jhin Jieh Lim, Edward Kai‐Hua Chow
Molecular Cancer (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 369
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma
Chris Jones, Suzanne J. Baker
Nature reviews. Cancer (2014) Vol. 14, Iss. 10, pp. 651-661
Open Access | Times Cited: 283
Inhibitors of Protein Methyltransferases and Demethylases
H. Ümit Kanıskan, Michael L. Martini, Jian Jin
Chemical Reviews (2017) Vol. 118, Iss. 3, pp. 989-1068
Open Access | Times Cited: 265
Inhibition of demethylases by GSK-J1/J4
Bo Heinemann, Jesper Morten Nielsen, Heidi Rye Hudlebusch, et al.
Nature (2014) Vol. 514, Iss. 7520, pp. E1-E2
Closed Access | Times Cited: 205
Histone demethylases in chromatin biology and beyond
Emilia Dimitrova, Anne H. Turberfield, Robert J. Klose
EMBO Reports (2015) Vol. 16, Iss. 12, pp. 1620-1639
Open Access | Times Cited: 197
Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology
Julian Blagg, Paul Workman
Cancer Cell (2017) Vol. 32, Iss. 1, pp. 9-25
Open Access | Times Cited: 197
Epigenetic treatment of solid tumours: a review of clinical trials
Clara Nervi, Elisabetta De Marinis, Giovanni Codacci-Pisanelli
Clinical Epigenetics (2015) Vol. 7, Iss. 1
Open Access | Times Cited: 195
Large hypomethylated blocks as a universal defining epigenetic alteration in human solid tumors
Winston Timp, Héctor Corrada Bravo, Oliver G. McDonald, et al.
Genome Medicine (2014) Vol. 6, Iss. 8
Open Access | Times Cited: 190
Histone methylation and the DNA damage response
Fade Gong, Kyle M. Miller
Mutation Research/Reviews in Mutation Research (2017) Vol. 780, pp. 37-47
Open Access | Times Cited: 189
LSD1: biologic roles and therapeutic targeting
Alba Maiqués-Díaz, Tim C. P. Somervaille
Epigenomics (2016) Vol. 8, Iss. 8, pp. 1103-1116
Open Access | Times Cited: 183
Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis
Qian Wang, Shuai Ma, Nan Song, et al.
Journal of Clinical Investigation (2016) Vol. 126, Iss. 6, pp. 2205-2220
Open Access | Times Cited: 181
Recent Progress in Histone Demethylase Inhibitors
Tom E. McAllister, Katherine S. England, Richard J. Hopkinson, et al.
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 4, pp. 1308-1329
Closed Access | Times Cited: 180
Targeting epigenetic regulators to overcome drug resistance in cancers
Nan Wang, Ting Ma, Bin Yu
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 154
LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials
Beatrice Noce, Elisabetta Di Bello, Rossella Fioravanti, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 75
Sound of silence: the properties and functions of repressive Lys methyltransferases
Chiara Mozzetta, Ekaterina Boyarchuk, Julien Pontis, et al.
Nature Reviews Molecular Cell Biology (2015) Vol. 16, Iss. 8, pp. 499-513
Closed Access | Times Cited: 174
A Systematic Review of Histone Lysine‐Specific Demethylase 1 and Its Inhibitors
Yi‐Chao Zheng, Jinlian Ma, Zhiru Wang, et al.
Medicinal Research Reviews (2015) Vol. 35, Iss. 5, pp. 1032-1071
Closed Access | Times Cited: 173
Polycomb-dependent epigenetic landscape in adult T-cell leukemia
Dai Fujikawa, Shota Nakagawa, Makoto Hori, et al.
Blood (2016) Vol. 127, Iss. 14, pp. 1790-1802
Open Access | Times Cited: 144
Epigenetic Regulation by Histone Demethylases in Hypoxia
Rebecca L. Hancock, Kate Dunne, Louise J. Walport, et al.
Epigenomics (2015) Vol. 7, Iss. 5, pp. 791-811
Open Access | Times Cited: 140
Highly selective inhibition of histone demethylases by de novo macrocyclic peptides
Akane Kawamura, Martin Münzel, Tatsuya Kojima, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 139
Page 1 - Next Page

Scroll to top